Links

Tools

Export citation

Search in Google Scholar

Updated Interim Analysis from Keynote-057: Pembrolizumab Monotherapy for Patients with High-risk Non-muscle-invasive Bladder Cancer (nmibc) Unresponsive to Bacillus Calmette-guerin (bcg)

Journal article published in 2019 by Arjun Balar ORCID
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown